Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1
1(100.0%)
1Total
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07299123Phase 1Enrolling By Invitation

Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA

Role: collaborator

NCT04198207Completed

The Effectiveness and Safety of Vagus Nerve Stimulation for TRE

Role: collaborator

NCT03865914Recruiting

Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy

Role: collaborator

NCT04958408Unknown

Deep Learning of Knee Joint MRI Intelligent Detection

Role: collaborator

NCT04025047Recruiting

A Multi-center Registry Study: The Follow-up the Complications for Trans-vaginal Mesh Surgery

Role: collaborator

All 5 trials loaded